Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a completed Phase 2 study of pembrolizumab and baseline C11-AMT PET imaging in metastatic melanoma. It includes study design, participation criteria, locations, outcome measures, and posted results.
    Difference
    61%
    Check dated 2026-11-09T12:57:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:37:07.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH announcement banner says federal agencies are transitioning from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T13:53:16.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to show a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-19T13:51:04.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the study page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with limited navigation, replacing the normal study content. The update appears to be a site wrapper change rather than changes to the study data itself.
    Difference
    20%
    Check dated 2026-09-21T19:58:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.